Hemispherx Biopharma appoints new CFO
This article was originally published in Scrip
Hemispherx Biopharma (US) has appointed Charles Bernhardt chief financial officer (interim), effective January 1st. Robert Peterson, Hemispherx's CFO for the past 20 years, is retiring at that time; he will retain a position of consultant and financial advisor to the company. Mr Bernhardt was most recently director of accounting for the healthcare division of Thomson Reuters.